The RSI indicator is headed upward, which confirms the positive momentum. Glenmark Pharma is retesting its breakout from a rounding bottom pattern on the daily chart and holding its 50 DEMA ...

Glenmark has received the Food and Drug Administration’s clearance for olopatadine hydrochloride ophthalmic solution, 0.2% OTC, which is the generic of Alcon’s Pataday Once Daily Relief ...

Glenmark Pharmaceuticals US subsidiary, Glenmark Pharmaceuticals Inc, USA, has received final approval from the United States Food & Drug Administration (US FDA) for Olopatadine Hydrochloride ...

Glenmark Pharmaceuticals Inc, USA, has received final approval from the United States Food & Drug Administration (US FDA) for Olopatadine Hydrochloride Ophthalmic Solution. Olopatadine Ophthalmic ...

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...

Bullish Engulfing 30 69 Apr 03, 2025 13:00 ...